Biodesix to present at the btig medtech, digital health, life science & diagnostic tools conference

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced scott hutton, chief executive officer of biodesix, will present in a fireside chat at the btig medtech, digital health, life science & diagnostic tools conference being held virtually february 15-17, 2022. btig medtech, digital health, life science & diagnostic tools conference date: wednesday, february 16, 2022 time: 4:30 pm et
BDSX Ratings Summary
BDSX Quant Ranking